PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- LOTENSIN
- Generic name / active ingredient
- benazepril hydrochloride immediate-release tablets
- Dosage-form class
- Dosage form and presentation as documented in the linked primary label
- Route
- Oral
- Record reviewed
- 2026-09-02
Copy from the pack in hand
Source-linked reading points
- The label carries a boxed warning for fetal toxicity. Contact the prescriber promptly for pregnancy, possible pregnancy or pregnancy planning; the site generates no continuation, stopping or substitution plan.
- Swelling of the face, lips, tongue or throat—especially with breathing or swallowing difficulty—is an emergency angioedema signal. Do not wait for a website assessment.
- ENTRESTO contains sacubitril/valsartan, and the label specifies a 36-hour boundary when switching to or from an ACE inhibitor such as benazepril. Do not self-schedule spacing, stopping or switching.
- Potassium supplements or salt substitutes, a potassium-sparing diuretic, another ACE inhibitor/ARB, NSAID, lithium or a diuretic on the same list requires priority review of kidney function, potassium, hypotension and the complete medicine list. Dehydration, unsteadiness or a fall in an older adult needs timely review.
Reviewed presentation examples — compare every field
- Benazepril hydrochloride 10 mg per tablet; 100-tablet bottleNDC 30698-448-01
- Benazepril hydrochloride 20 mg per tablet; 100-tablet bottleNDC 30698-449-01
- Benazepril hydrochloride 40 mg per tablet; 100-tablet bottleNDC 30698-450-01